


Fostering Collaboration: Technophage Joins REVERSE 2 Investigator Meeting in Hyderabad to Advance TP-102 Development
We are delighted to share that Technophage’s Clinical Trial Director, Margarida Barreto, participated in the REVERSE 2 / TP-102_102 Investigator Meeting on 19th January 2025 in Hyderabad, India. The event was promoted and organized by our colleagues at VectorB2B...
Technophage is looking for a Phage Scientist to join the team
Technophage is currently seeking a Phage Scientist to join our Research team. The ideal candidate will hold an MSc or PhD in Biology, Biochemistry, or a related Life Sciences field, with at least three years of laboratory experience in phage biology. Proficiency in...
TP-102 Phase I/IIa clinical trial results published in Med by Cell Press
Technophage is excited to kick off the new year by sharing our latest publication in Med by Cell Press. Our Phase I/IIa study results for TP-102, an innovative bacteriophage cocktail targeting infected diabetic foot ulcers, demonstrated promising outcomes and are...